Literature DB >> 7731678

Identification of the sites of interaction between c-Raf-1 and Ras-GTP.

D Barnard1, B Diaz, L Hettich, E Chuang, X F Zhang, J Avruch, M Marshall.   

Abstract

Specific sites of protein-protein interaction were identified in the 51-149 region of c-Raf-1 using contact epitope scanning and site-directed mutagenesis. Nineteen overlapping peptides based upon the primary sequence of the Ras binding domain of c-Raf-1 were tested for the ability to competitively inhibit complex formation between Ras-GTP and the c-Raf-1 N-terminus. A peptide containing c-Raf-1 residues 91-105 as well as five overlapping peptides covering a region extending from residues 118 to 143 interfered with Ras association, defining these sites as potential contact surfaces with Ras. Alanine scanning mutagenesis was used as a second probe for sites of Ras interaction with the c-Raf-1 N-terminus. Raf residues 64-67 and 80-103 were demonstrated as important for association with Ras-GTP with residues 66, 67, 84, 87, 89 and 91 identified as the most critical individual points of contact with the Ras protein. Alanine substitution of residues between 118-143 suggested only one potentially weak site of interaction defined by residues 120-125. The combined results of both peptide and mutagenic analyses suggest that the primary site of c-Raf-1 interaction with Ras maps to Raf residues 80-103, with secondary interactions occurring with residues 66 and 67 and possibly 120-125. Contact epitope scanning of the Ras effector region found maximum inhibition of Ras/Raf association with a peptide corresponding to Ras amino acids 37-51. A model is proposed for the GTP-dependent association of Ras and Raf.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731678

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

Review 1.  Insulin signal transduction through protein kinase cascades.

Authors:  J Avruch
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

2.  RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao.

Authors:  S Traver; C Bidot; N Spassky; T Baltauss; M F De Tand; J L Thomas; B Zalc; I Janoueix-Lerosey; J D Gunzburg
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

3.  Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.

Authors:  M Foschi; S Chari; M J Dunn; A Sorokin
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

Review 4.  Signal transduction pathways and their relevance in human astrocytomas.

Authors:  M M Feldkamp; N Lau; A Guha
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

5.  Rheb interacts with Raf-1 kinase and may function to integrate growth factor- and protein kinase A-dependent signals.

Authors:  W M Yee; P F Worley
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ.

Authors:  Z Luo; B Diaz; M S Marshall; J Avruch
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

7.  Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor.

Authors:  Matthew L Edin; Rudy L Juliano
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

8.  TLN-4601 suppresses growth and induces apoptosis of pancreatic carcinoma cells through inhibition of Ras-ERK MAPK signaling.

Authors:  Paul M Campbell; Nadia Boufaied; James J Fiordalisi; Adrienne D Cox; Pierre Falardeau; Channing J Der; Henriette Gourdeau
Journal:  J Mol Signal       Date:  2010-11-02

9.  Aphanin, a triterpenoid from Amoora rohituka inhibits K-Ras mutant activity and STAT3 in pancreatic carcinoma cells.

Authors:  Thangaiyan Rabi; Carlo V Catapano
Journal:  Tumour Biol       Date:  2016-06-22

Review 10.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.